Aaron Rosenberg Biography and Net Worth

CFO of BeOne Medicines

Aaron Rosenberg joined BeOne in July 2024 as Chief Financial Officer.

Most recently, Mr. Rosenberg was Senior Vice President and Corporate Treasurer of Merck. Prior to his role as Corporate Treasurer, Mr. Rosenberg served as Senior Vice President of Corporate Strategy and Planning at Merck with responsibilities including leading the enterprise-wide business transformation team and acting as Head of Financial Planning & Analysis. Prior to that, Mr. Rosenberg was Vice President and Finance Lead of Merck Animal Health, leading a global team of 120 colleagues. He joined Merck in 2003 in ascending leadership roles in the global finance organization.

Mr. Rosenberg earned a B.S. in finance from the University of Florida and an MBA from New York University.

How do I contact Aaron Rosenberg?: The corporate mailing address for Mr. Rosenberg and other BeOne Medicines executives is C/O MOURANT GOVERNANCE SERVICES (CAYMAN), 94 SOLARIS AVENUE, CAMANA BAY, GRAND CAYMAN, E9, KY1-1108. BeOne Medicines can also be reached via phone at 13459494123 and via email at [email protected]. Learn More on Aaron Rosenberg's contact information.
Has Aaron Rosenberg been buying or selling shares of BeOne Medicines?: Aaron Rosenberg has not been actively trading shares of BeOne Medicines over the course of the past ninety days. Most recently, Aaron Rosenberg sold 1,190 shares of the business's stock in a transaction on Friday, August 1st. The shares were sold at an average price of $290.47, for a transaction totalling $345,659.30. Learn More on Aaron Rosenberg's trading history.
Who are BeOne Medicines' active insiders?: BeOne Medicines' insider roster includes Chan Lee (SVP), John Oyler (CEO), Aaron Rosenberg (CFO), Corsee Sanders (Director), Corsee Sanders (Director), Lai Wang (Global Head of R&D), Lai Wang (Insider), Xiaodong Wang (Insider), and Xiaobin Wu (COO). Learn More on BeOne Medicines' active insiders.
Are insiders buying or selling shares of BeOne Medicines?: In the last twelve months, insiders at the sold shares 51 times. They sold a total of 1,475,419 shares worth more than $391,016,020.22. The most recent insider tranaction occured on November, 26th when Director Corazon (Corsee) D Sanders sold 2,627 shares worth more than $895,544.30. Insiders at BeOne Medicines own 6.6% of the company. Learn More about insider trades at BeOne Medicines.
Information on this page was last updated on 11/26/2025.

Aaron Rosenberg Insider Trading History at BeOne Medicines

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/1/2025	Sell	1,190	$290.47	$345,659.30

Aaron Rosenberg Buying and Selling Activity at BeOne Medicines

BeOne Medicines Company Overview

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

Today's Range

Now: $331.40

$330.98

$340.98

50 Day Range

MA: $332.91

$308.22

$377.47

2 Week Range

Now: $331.40

$170.99

$385.22

Volume

239,751 shs

Average Volume

310,848 shs

Market Capitalization

$39.28 billion

P/E Ratio

649.80

Dividend Yield

N/A

Beta

0.45